HCC or hepatocellular carcinoma can result in patients getting liver diseases such as viral hepatitis and non-alcoholic fatty liver disease with cirrhosis due to disease progression. New data from recent researches shows factors that improve early detection and diagnosis, and risks prior to HCC and during treatment.
Spero Therapeutics granted $15.7 million for research on SPR994, its oral carbapenem-class candidate, to study the drug’s efficacy against biological threats like anthrax, plague and melioidosis as a part of an interagency collaboration.
Royal Free London NHS Foundation Trust and Teesside University researchers helped organize a ‘hackathon’ on 4 and 5 July 2018 at Brunel University in London with an aim to develop virtual reality (VR) tools for patients.
The U.S. Food and Drug Administration approved the first autonomous artificial intelligence diagnostic system, IDx-DR and the University of Iowa Healthcare has become the first healthcare organization to implement it.
Onychomycosis is a fungal infection that causes nail disfigurement, pain and infection and impacts millions of people throughout the world. Though several antifungal treatments are currently available, they often fail for various reasons.
Kibbutz Shefayim from an Israel-based startup company named Zebra Medical Vision announced that it has successfully received FDA clearance for an algorithm, which could aid physicians to quantify a patient’s coronary artery calcification.
On Tuesday the analysis results of a yearlong comparative study of hospital admission rates between diabetes patients using insulin pumps and those taking multiple daily injections of insulin were released by Medtronic (NYSE: MDT) and UnitedHealthcare (NYSE: UNH).
SMART Brain Aging, Inc. announced its one-on-one patient intervention program for aging brain health, Brain U Online, now available to adults above age 50 via online subscription and iOS app, Brain U Lite. Five years of clinical trials were carried out with more than 3,000 participants at Harvard Medical School/Boston University School of Medicine to develop this new program
Gene editing and gene therapy can delete disease-causing genes in order to treat specific diseases. But the skill to control unwanted genes is a point of concern, as it might cause severe side effects. A research team from Cardiff University and the University of Bath have devised a switch to control protein expression in mouse embryos, which could be used in human gene therapies in future.
Telemedicine services are gaining entry into Japanese hospitals. Royal Philips recently announced its deal with Showa University in Japan in order to launch the first telemedicine intensive care program (eICU) at Showa Koto Toyosu Hospital and Showa University Hospital. This program will reduce mortality rates and increase savings as well as case volume.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.